Xtant Medical Holdings Profit Margin

The latest profit margin for XTNT is 1.5% as of March 2026. That compares with -9.81% in the prior-year period — up 115.3% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside Xtant Medical Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, XTNT's profit margin moved from -9.81% to 1.5% — a 115.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xtant Medical Holdings's valuation or profitability profile.

Against Healthcare companies, XTNT currently prints 1.5% for profit margin, while the sector average sits near 15.52%. That is roughly 90.3% below the sector mean. Large gaps often invite a closer look at Xtant Medical Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Xtant Medical Holdings converts resources into returns. At 1.5%, XTNT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.81% in the prior-year period — up 115.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XTNT's profit margin (1.5%), review year-over-year change from -9.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.